Common questions about Elocom 0.1% (FAQ)
Q: What are the main skin conditions that Elocom 0.1% is approved to treat?
A: Mometasone furoate topical cream 0.1% is officially indicated for the relief of the inflammatory and pruritic (itchy) manifestations of various skin diseases that respond to corticosteroids. This general indication applies to patients aged 2 years and older.
Q: What is the difference between Elocom cream and Elocom ointment?
A: Official product information states that the different forms (cream, ointment, solution) use varied base ingredients, or vehicles. Ointments are described as typically oilier and more occlusive, properties which are often associated with treating very dry or scaly skin. Creams are less greasy and tend to absorb more quickly.
Q: What are the risks of using Elocom 0.1% on sensitive areas like the groin or underarms?
A: Regulatory information states the use of Elocom 0.1% should generally be avoided on sensitive areas such as the underarms (axillae) or groin unless prescribed by a healthcare professional. These areas, particularly skin folds, carry an increased risk of local skin side effects, such as skin thinning (atrophy), and may increase the systemic absorption of the medicine.
Q: Why is it generally advised not to use Elocom on the eyelids or near the eyes?
A: Elocom 0.1% is strictly not for ophthalmic use and should be kept away from the eyes. Regulatory documents caution that contact with the eyes should be avoided and that prolonged use near the eyes is associated with a rare risk of developing subcapsular cataracts or glaucoma. The official information notes that visual changes should be brought to a healthcare professional's attention.
Q: Is it safe to apply Elocom to skin that is broken, cut, or weeping?
A: The official prescribing information contraindicates the use of this medicine on wounds, ulcerated skin, or where there is severe skin injury. Applying Elocom 0.1% to broken or damaged skin can increase the amount of medicine absorbed into the body, potentially increasing the risk of side effects.
Q: What is HPA axis suppression and how is it related to topical steroids like Elocom?
A: HPA axis suppression is a serious, but rare and reversible, side effect linked to the systemic absorption of the steroid. The HPA axis is a complex system that regulates the body's natural production of corticosteroids (stress hormones). The risk is linked to factors such as long-term use, the potency of the steroid, and application over large areas of the body.
Q: Does Elocom 0.1% cause acne or small red bumps (folliculitis) in the treated area?
A: Official product labeling notes that acne-like rashes (acneiform eruptions) and inflammation of hair follicles (folliculitis) are listed as potential adverse reactions that have been reported with topical corticosteroids. The medicine is also generally contraindicated for use on existing acne.
Q: What other skin conditions, besides eczema and psoriasis, should Elocom be avoided for?
A: The official prescribing information states that Elocom 0.1% is contraindicated (must not be used) on several pre-existing skin conditions. These include facial rosacea, acne vulgaris, perioral dermatitis, diaper rash (napkin eruptions), and most untreated active skin infections (e.g., viral, bacterial, or fungal).
Q: Is Elocom effective for treating scalp conditions like scalp psoriasis?
A: The topical lotion or solution formulation is generally indicated for corticosteroid-responsive inflammatory conditions. Although not specifically naming 'scalp psoriasis,' the indication covers inflammatory skin conditions that respond to the drug, particularly in hair-bearing areas for patients 12 years of age and older.
Q: What is the appropriate use period for Elocom 0.1% on the face, if prescribed for that area?
A: Official documents indicate that application to the face should generally be avoided unless directed by a healthcare professional. If use on the face is prescribed, the duration of treatment courses is generally limited to 5 days, and occlusive dressings should not be used in the area.
Q: Can Elocom 0.1% cause changes in skin color, such as lightening of the treated area?
A: Yes, official post-marketing reports for topical corticosteroids include hypopigmentation as a possible adverse reaction. This describes the lightening of the normal skin color in the treated area.
Q: What is a 'topical steroid withdrawal' reaction and how is it described by official sources?
A: Regulatory documents caution that if potent topical treatment has been used long-term, suddenly stopping it can lead to a rebound phenomenon. This reaction is described as a dermatitis that may present with intense redness, stinging, and burning in the area where the medicine was applied.
Q: Can Elocom 0.1% cause stretch marks (striae) with prolonged use?
A: Official adverse reaction reports for this class of medicine list skin striae (stretch marks) as a possible side effect. This is typically associated with the prolonged use or misuse of the medication.
Q: What signs or symptoms could indicate that too much Elocom is being absorbed into the body?
A: Official information suggests signs of possible systemic absorption to be aware of, which may include unusual or extreme tiredness, swelling of the ankles or feet, excessive thirst or urination, or changes in vision. If these signs appear, official sources indicate that professional guidance should be sought immediately.
Q: Is increased hair growth (hypertrichosis) a known, but rare, side effect of Elocom?
A: Official post-marketing reports for topical corticosteroids include hypertrichosis (excessive hair growth) as a known adverse reaction.
Q: Can using Elocom interfere with routine vaccinations in children?
A: General warnings for corticosteroids indicate that their use may potentially reduce the body's ability to fight off certain infections. Official warnings indicate that professional guidance is necessary concerning the use of any corticosteroid product near the time of routine vaccinations.
Q: Are there reported side effects related to the non-active ingredients in the cream or ointment?
A: Yes. Some regulatory documents note that specific non-active ingredients, or excipients, such as Propylene glycol (in certain formulations), may cause skin irritation. The medicine is formally contraindicated if a patient has a known hypersensitivity to any of the product's components.
Q: Does Elocom 0.1% contain any substances that are known to cause allergic contact dermatitis?
A: Allergic contact dermatitis is listed as a possible adverse reaction to this class of medicine in official documents. The product is strictly contraindicated if there is a known hypersensitivity to the active drug or any of the non-active components in the preparation being used.
Q: What should be done if Elocom is accidentally swallowed?
A: If accidental swallowing or overdose is suspected, official sources state that immediate professional guidance is required. Official sources indicate that in the event of suspected accidental swallowing or overdose, contacting a poison control center or an emergency room is necessary.
